Cancer stem cell targeted therapy: progress amid controversies

  • Tao Wang
    School of Nursing, Zhengzhou University, Zhengzhou, China
  • Sarah Shigdar
    School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
  • Michael P. Gantier
    Centre for Cancer Research, Hudson Institute of Medical Research, Clayton, Victoria, Australia
  • Yingchun Hou
    Co-Innovation Center for Qinba Region's Sustainable Development, Shaanxi Normal University, Xi'an, China
  • Li Wang
    Department of Gynecologic Oncology, Henan Cancer Hospital, The Affiliated Cancer Hospital of Zhengzhou University, Zhengzhou, China
  • Yong Li
    Cancer Care Centre, St George Hospital and St George Clinical School, University of New South Wales (UNSW), Kensington, Australia
  • Hadi Al Shamaileh
    School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
  • Wang Yin
    School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia
  • Shu-Feng Zhou
    Department of Pharmaceutical Sciences, College of Pharmacy, University of South Florida, Tampa, FL, USA
  • Xinhan Zhao
    Department of Medical Oncology, The First Affiliated Hospital of Xi'an Jiaotong University School of Medicine, Xi'an, China
  • Wei Duan
    School of Medicine, Deakin University, Waurn Ponds, Victoria, Australia

収録刊行物

  • Oncotarget

    Oncotarget 6 (42), 44191-44206, 2015-10-19

    Impact Journals, LLC

被引用文献 (6)*注記

もっと見る

詳細情報 詳細情報について

問題の指摘

ページトップへ